Tests of reference samples showed that the batches covered by the decision do not meet the requirements for atomoxetine content, and batch 1311190 also fails the uniformity of mass parameter, which poses a real and direct risk to patients’ health. Potential effects: reduced treatment efficacy, risk of symptom worsening, possible complications resulting from improper dosing.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the specified batches of the medicine; check the batch number on the packaging and, if you have the product, return it to the pharmacy and consult a doctor or pharmacist.
Distribution of the specified batches of Konaten was suspended throughout the country and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related